[The preclinical assessment of the activity and pharmacological action of native human interleukin-2]

Patol Fiziol Eksp Ter. 1990 Mar-Apr:(2):32-4.
[Article in Russian]

Abstract

It was demonstrated in in vivo and in vitro experiments that interleukin-2, obtained by cultivation of donor lymphocytes and purified by gel filtration, induces the production of mouse and human killer lymphocytes possessing high cytolytic activity against tumor cells. Interleukin-2 does not cause irreversible changes of the physiological and morphologic indices of vital activity in mice.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Animals
  • Antineoplastic Agents*
  • Cytotoxicity Tests, Immunologic / methods
  • Drug Screening Assays, Antitumor
  • Female
  • Humans
  • Interleukin-2 / isolation & purification
  • Interleukin-2 / pharmacology
  • Interleukin-2 / therapeutic use*
  • Interleukin-2 / toxicity
  • Killer Cells, Lymphokine-Activated / drug effects
  • Killer Cells, Lymphokine-Activated / immunology
  • Leukemia P388 / drug therapy
  • Leukemia P388 / immunology
  • Lymphocytes / drug effects
  • Lymphocytes / immunology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred DBA
  • Time Factors
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / immunology

Substances

  • Antineoplastic Agents
  • Interleukin-2